{"pmid":32362681,"pmcid":"PMC7189907","title":"Indian Society of Anaesthesiologists (ISA National) Advisory and Position Statement regarding COVID-19.","text":["Indian Society of Anaesthesiologists (ISA National) Advisory and Position Statement regarding COVID-19.","Indian J Anaesth","Malhotra, Naveen","Joshi, Muralidhar","Datta, Rashmi","Bajwa, Sukhminder Jit Singh","Mehdiratta, Lalit","32362681"],"journal":"Indian J Anaesth","authors":["Malhotra, Naveen","Joshi, Muralidhar","Datta, Rashmi","Bajwa, Sukhminder Jit Singh","Mehdiratta, Lalit"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362681","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.4103/ija.IJA_288_20","topics":["Prevention"],"weight":1,"_version_":1666138496046202880,"score":9.490897,"similar":[{"pmid":32307116,"pmcid":"PMC7144667","title":"Role of anaesthesiologists during the COVID-19 outbreak in China.","text":["Role of anaesthesiologists during the COVID-19 outbreak in China.","Br J Anaesth","Yang, Manping","Dong, Hailong","Lu, Zhihong","32307116"],"journal":"Br J Anaesth","authors":["Yang, Manping","Dong, Hailong","Lu, Zhihong"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307116","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.bja.2020.03.022","keywords":["covid-19","china","airway management","anaesthesiologist","coronavirus","critical care","infection control","rapid response team"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138491148304384,"score":58.95136},{"pmid":32317433,"title":"All India Ophthalmological Society - Indian Journal of Ophthalmology consensus statement on preferred practices during the COVID-19 pandemic.","text":["All India Ophthalmological Society - Indian Journal of Ophthalmology consensus statement on preferred practices during the COVID-19 pandemic.","The COVID-19 pandemic has taken tragic proportions and has disrupted lives globally. In the wake of governmental lockdowns, ophthalmologists need practical and actionable guidelines based on advisories from national health departments on how to conduct their duties during nationwide lockdowns and after these are lifted. In this paper, we present a preferred practice pattern (PPP) based on consensus discussions between leading ophthalmologists and health care professionals in India including representatives from major governmental and private institutions as well as the All India Ophthalmological Society leadership. In this document, the expert panel clearly defines the range of activities for Indian ophthalmologists during the ongoing lockdown phase and precautions to be taken once the lockdown is lifted. Guidelines for triage, governmental guidelines for use of personal protective equipment from ophthalmologists' point of view, precautions to be taken in the OPD and operating room as well as care of various ophthalmic equipment have been described in detail. These guidelines will be applicable to all practice settings including tertiary institutions, corporate and group practices and individual eye clinics and should help Indian ophthalmologists in performing their professional responsibilities without being foci of disease transmission.","Indian J Ophthalmol","Sengupta, Sabyasachi","Honavar, Santosh G","Sachdev, Mahipal S","Sharma, Namrata","Kumar, Atul","Ram, Jagat","Shetty, Rohit","Rao, Girish S","Ramasamy, Kim","Khanna, Rohit","Jain, Elesh","Bhattacharjee, Kasturi","Agarwal, Ashvin","Natarajan, S","Lahane, Tatyarao P","32317433"],"abstract":["The COVID-19 pandemic has taken tragic proportions and has disrupted lives globally. In the wake of governmental lockdowns, ophthalmologists need practical and actionable guidelines based on advisories from national health departments on how to conduct their duties during nationwide lockdowns and after these are lifted. In this paper, we present a preferred practice pattern (PPP) based on consensus discussions between leading ophthalmologists and health care professionals in India including representatives from major governmental and private institutions as well as the All India Ophthalmological Society leadership. In this document, the expert panel clearly defines the range of activities for Indian ophthalmologists during the ongoing lockdown phase and precautions to be taken once the lockdown is lifted. Guidelines for triage, governmental guidelines for use of personal protective equipment from ophthalmologists' point of view, precautions to be taken in the OPD and operating room as well as care of various ophthalmic equipment have been described in detail. These guidelines will be applicable to all practice settings including tertiary institutions, corporate and group practices and individual eye clinics and should help Indian ophthalmologists in performing their professional responsibilities without being foci of disease transmission."],"journal":"Indian J Ophthalmol","authors":["Sengupta, Sabyasachi","Honavar, Santosh G","Sachdev, Mahipal S","Sharma, Namrata","Kumar, Atul","Ram, Jagat","Shetty, Rohit","Rao, Girish S","Ramasamy, Kim","Khanna, Rohit","Jain, Elesh","Bhattacharjee, Kasturi","Agarwal, Ashvin","Natarajan, S","Lahane, Tatyarao P"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317433","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.4103/ijo.IJO_871_20","keywords":["covid-19","consensus","guidelines","lockdown","ophthalmology","pandemic","precautions","preferred practice"],"locations":["India","Indian","Indian"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666138493747724288,"score":50.544697},{"pmid":32405088,"pmcid":"PMC7219407","title":"Cardiological society of India position statement on COVID-19 and heart failure.","text":["Cardiological society of India position statement on COVID-19 and heart failure.","The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority.","Indian Heart J","Harikrishnan, S","Mohanan, P P","Chopra, V K","Ambuj, Roy","Sanjay, G","Manish, Bansal","Chakraborty, R N","Chandra, Sharad","Chattarjee, S S","Chopra, H K","Mathew, Cibu","Deb, P K","Goyal, A","Goswami, K C","Gupta, R","Guha, S","Gupta, V","Hasija, P K","Wardhan, Harsh","Jabir, A","Jayagopal, P B","Kahali, D","Katyal, V K","Kerkar, P G","Khanna, N N","Majumder, B","Mandal, M","Meena, C B","Naik, N","Narain, V K","Pathak, L A","Ray, S","Roy, D","Sarma, D","Shanmugasundaram, S","Singh, B P","Tyagi, S K","Venugopal, K","Wander, G S","Yadav, R","Das, M K","32405088"],"abstract":["The COVID 19 global pandemic has engulfed humanity with a huge impact on health systems across the world. Many patients develop myocardial injury which can lead to significant cardiovascular complications including HF. This will require aggressive management strategies which are evolving. Guideline directed drug therapy including ACEI/ARB/ARNI is to be continued in patients with pre-existing HF. Long-term cardiovascular effects of COVID-19 are yet to be ascertained. Protection of health care personnel from contracting the disease should be given high priority."],"journal":"Indian Heart J","authors":["Harikrishnan, S","Mohanan, P P","Chopra, V K","Ambuj, Roy","Sanjay, G","Manish, Bansal","Chakraborty, R N","Chandra, Sharad","Chattarjee, S S","Chopra, H K","Mathew, Cibu","Deb, P K","Goyal, A","Goswami, K C","Gupta, R","Guha, S","Gupta, V","Hasija, P K","Wardhan, Harsh","Jabir, A","Jayagopal, P B","Kahali, D","Katyal, V K","Kerkar, P G","Khanna, N N","Majumder, B","Mandal, M","Meena, C B","Naik, N","Narain, V K","Pathak, L A","Ray, S","Roy, D","Sarma, D","Shanmugasundaram, S","Singh, B P","Tyagi, S K","Venugopal, K","Wander, G S","Yadav, R","Das, M K"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405088","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ihj.2020.04.012","keywords":["covid-19","csi","heart failure","cardiology","corona"],"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666802845342498817,"score":45.86214},{"pmid":32461494,"title":"Comments on: All India Ophthalmic Society-Indian Journal of Ophthalmology Consensus statement on preferred practices during COVID-19 Pandemic.","text":["Comments on: All India Ophthalmic Society-Indian Journal of Ophthalmology Consensus statement on preferred practices during COVID-19 Pandemic.","Indian J Ophthalmol","Sampangi, Raju","Hemalatha, B C","32461494"],"journal":"Indian J Ophthalmol","authors":["Sampangi, Raju","Hemalatha, B C"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461494","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.4103/ijo.IJO_1130_20","link_comment_for":"32317433","weight":0,"_version_":1668079521295761409,"score":45.67514},{"pmid":32278018,"pmcid":"PMC7141642","title":"Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.","text":["Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.","Indian Pacing Electrophysiol J","Kapoor, Aditya","Pandurangi, Ulhas","Arora, Vanita","Gupta, Anoop","Jaswal, Aparna","Nabar, Ashish","Naik, Ajay","Naik, Nitish","Namboodiri, Narayanan","Vora, Amit","Yadav, Rakesh","Saxena, Anil","32278018"],"journal":"Indian Pacing Electrophysiol J","authors":["Kapoor, Aditya","Pandurangi, Ulhas","Arora, Vanita","Gupta, Anoop","Jaswal, Aparna","Nabar, Ashish","Naik, Ajay","Naik, Nitish","Namboodiri, Narayanan","Vora, Amit","Yadav, Rakesh","Saxena, Anil"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32278018","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ipej.2020.04.003","keywords":["covid-19","heart disease","hydroxychloroquine","qtc interval","torsade de pointes"],"e_drugs":["Hydroxychloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138491644280832,"score":43.878}]}